ASAM the Honorable Gene Digirolamo President-Elect House Human Services Committee William F
oF Aon,^ .d.{ .eo': '10 "r A S A M tll::[3[',':fi:1,'J -<jhrrB :g" OFFICERS June 18,20L9 President Paul H. Earley, MD, DFASAM The Honorable Gene DiGirolamo President-Elect House Human Services Committee William F. Haning, III, MD, DFAPA, DFASAM East Wing Building, Room 49 Vice President Harrisburg, PALTI2O Yngvild K. Olsen, MD, MPH, DFASAM Secretary Re: Opposition to 58675 JeffreySelzer, MD, DFASAM Treasurer Dear Kenneth L Freedman, MD, MS, MBA, FACP, DFASAM Chairman DiGirolamo and members of the House Human Services lmmediate Past President Committee, Kelly l. Clarh MD, MBA, DFAPA, DFASAM On behalf of the American Society of Addiction Medicine (ASAM) and the BOARD OF DIRECTORS Pennsylvania Society of Addiction Medicine (PSAM), we would like to take Directors-at-Large this opportunity to provide our opposition 58675. Anthony Albanese, MD, DFASAM to With the opioid addiction Adam J. Cordon, MD, MPH, FACP, DFASAM and overdose epidemic significantly impacting the country and Brian Hurle, MD, MBA, DFASAM Pennsylvania, ASAM and PSAM are concerned that the duplicative Margaret Jarvis, MD, DFASAM certification requirements established by the bill, as well as the proposed Marla D. Kushner, DO, FSAHM, FACOFP, DFASAM licensing fee for Office-Based Opioid Treatment (OBOT) practices as TimothyWiegand, MD, FACMT, FMCT, DFASAM outlined in 58675 will result in decreased access to lifesaving care. We cannot REGIONAL DIRECTORS support the bill in its current form. Anika, Alvanzo, MD, MS, FACP, DFASAM Gavin Bart, MD, PhD, DFASAM ASAM and PSAM are dedicated to increasing access to and improving the Gregory X. Boehm, MD, DFASAM quality of addiction treatment for patients in Pennsylvania and across the Murtuza Ghadiali, MD, FASAM nation.
[Show full text]